Globe Newswire (Thu, 23-Jul 3:09 AM ET)
Genenta-Backed Sphia High Tech Reports Fiscal Year 2025 Results
Globe Newswire (Wed, 22-Jul 4:00 AM ET)
Genenta’s Bold Shift: Strategic Transformation and Defense Sector Expansion Signal New Era for GNTA
Market Chameleon (Tue, 27-Jan 4:53 AM ET)
Market Chameleon (Fri, 24-Oct 5:52 AM ET)
Market Chameleon (Fri, 24-Oct 3:05 AM ET)
Genenta Science SPA is an industrial consolidator focused on acquiring majority or full ownership of privately held, established companies operating in Italian national-security-regulated sectors. Its acquisition activities span aerospace, defense, national security (including cybersecurity), and biotechnology/biosecurity, with a focus on businesses covered by Italy's Golden Power legislation.
Genenta Science S.P.A. - American Depositary Shares trades on the NASDAQ stock market under the symbol GNTA.
As of September 10, 2026, GNTA stock price declined to $0.86 with 20,549 million shares trading.
GNTA has a beta of 0.25, meaning it tends to be less sensitive to market movements. GNTA has a correlation of 0.00 to the broad based SPY ETF.
GNTA has a market cap of $20.18 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, GNTA traded as high as $10.00 and as low as $.55.
GNTA has underperformed the market in the last year with a price return of -74.8% while the SPY ETF gained +17.7%. GNTA has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -46.2% and -23.8%, respectively, while the SPY returned +3.1% and -1.1%, respectively.
GNTA support price is $.82 and resistance is $.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GNTA shares will trade within this expected range on the day.